Kampala Residents Urged to Embrace Yellow Fever Vaccination

This campaign, which commenced on April 2nd, will continue until April 8th.

Dorothy Kisaka, the Executive Director of Kampala Capital City Authority (KCCA), has urged city residents to actively engage in the current yellow fever vaccination campaign.

Yesterday, Kisaka toured various vaccination sites in Kampala to assess progress and encourage city dwellers to embrace the immunization campaign.

Kisaka’s personal involvement in overseeing the vaccination efforts was evident as she visited Komamboga Health Center III and Kawala Health Center IV, both part of the extensive network of over 15 vaccination sites established across the city.

During her visits, Kisaka emphasized the critical importance of timely immunization, stressing that the yellow fever vaccine offers lifelong protection against the disease.

The Yellow Fever Vaccination Campaign, covering 53 districts throughout Uganda, has received a positive response in Kampala. This campaign, which commenced on April 2nd, will continue until April 8th.

Kisaka urged Kampala residents to seize the opportunity and get vaccinated, stating, “The exercise in Kampala is progressing well in all our five divisions. I appeal to all people to go for yellow fever vaccination. Don’t delay; go and get your jab.”

The campaign has seen a favorable turnout in Kampala, with Dr. Annet Kisakye from the World Health Organization (WHO) Uganda commending the efforts of stakeholders in driving the campaign forward and encouraging participation among city dwellers.

Previously, the yellow fever vaccine was primarily available through private health providers at a cost, mainly targeting travelers.

However, the ongoing mass immunization effort ensures free access to the vaccine for all citizens aged between 1 and 60 years, excluding pregnant women, breastfeeding mothers, and individuals allergic to eggs.

Citizens are encouraged to visit their nearest government health facility or designated vaccination points for a free jab.

Comments are closed.